Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...

As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works ...

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

In every corner of the FDA, and at sister health agencies like the CDC, support staff, specialists, and scientists were hit with DOGE pink slips.

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.

The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. | The ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

Cell membrane proteins hide secret gateways that can be used to modify cell behavior. This has been demonstrated in a study ...

Commonsense management measures can help keep arthritic horses comfortable and sound even in the coldest weather.